Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...
Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...
Studies show that 1 in 3 American adults has prediabetes - but 8 in 10 of them don't know it. For the millions of Americans with undetected prediabetes or early metabolic dysfunction, accessible ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...
Biochemist Svetlana Mojsov, PhD, has been awarded the Frontiers of Knowledge Award in Biology and Biomedicine, presented by Spain’s BBVA Foundation, for her collaborative research with Daniel Drucker, ...
Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension ...
GLP-1 medications aid weight loss, but experts emphasise supervised care, diagnostics, nutrition, and lifestyle changes for ...
Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...
NEW YORK--(BUSINESS WIRE)--Nourish, the leading metabolic health provider powered by the largest dietitian network in the country, today announced the launch of Nourish Labs, a new program that gives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results